ArticleCannabis and cannabinoid research2023

CB1 Receptor Silencing Attenuates Ketamine-Induced Hyperlocomotion Without Compromising Its Antidepressant-Like Effects.

Pedro Henrique Gobira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.